Ingestible Vital Signs Monitor Shows Promise in First-in-Human Trial

New device developed by a company founded by Brigham researchers detected an opioid-overdose in preclinical models and captured respiratory rates and heart rates in 10 patients with sleep apnea
Source: BWH News - Category: Hospital Management Source Type: news